BTW
CVET

Boston Trust Walden’s Covetrus, Inc. Common Stock CVET Stock Holding History

Boston Trust Walden’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-103,836
Closed -$3.31M – 387
2019
Q1 		$3.31M Buy
+103,836
New +$3.69M 0.05% 256

Other funds holding CVET

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Boston Trust Walden's CVET Position: Q2 2019 in Review

Boston Trust Walden sold out of Covetrus, Inc. Common Stock (CVET) in Q2 2019, closing a stake of 103,836 shares — an estimated $3.31M sold.

Boston Trust Walden first reported a position in CVET in Q1 2019 and held it in 1 quarter. The position peaked at $3.31M in Q1 2019. 321 funds tracked by Wall St. Rank hold CVET as of Q2 2019.

  • Boston Trust Walden reported no remaining Covetrus, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Boston Trust Walden sold 103,836 Covetrus, Inc. Common Stock shares in Q2 2019, an estimated $3.31M.
  • Boston Trust Walden first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Boston Trust Walden's Covetrus, Inc. Common Stock position peaked at $3.31M in Q1 2019.
  • 321 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q2 2019.

Based on Boston Trust Walden's 13F filing for Q2 2019, filed 25 Jul 2019.